 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Citing Validation Costs, IP Concerns, Reference Labs Offer Gloomy Take on Protein Biomarker Tests
May 25, 2012
Citing Validation Costs, IP Concerns, Reference Labs Offer Gloomy Take on Protein Biomarker Tests
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BGI Aims to Expand Proteomics Services, Purchase 50-Plus New Mass Spectrometers
June 17, 2011 / ProteoMonitor - NCI Kicks Off Second Stage of Clinical Proteomic Technologies for Cancer Initiative
August 26, 2011 / ProteoMonitor - NCI's CPTC Issues Call for Antibody Targets
April 20, 2012 / ProteoMonitor - Calling for Stronger Clinical Focus, Researchers Question Priorities of NCI's CPTAC Initiative
February 17, 2012 / ProteoMonitor - E-SAC Wins $4.72M Contract for CPTC Data Center
October 7, 2011 / ProteoMonitor